Molekule, a science and clean technology company based in San Francisco, has introduced the world’s first molecular air purifier. Their innovation brings a new approach to air purification by breaking pollutants down on a molecular level rather than merely catching them and filtering them like other air purifiers.

The Environemtal Protection Agency of the United States estimates that indoor air can be up to five times more polluted than outdoor air. And that’s pretty bad news given that the average person spends 90% of their time indoors. Indoor air and the quality of this air is therefore an issue that adversely affects us all, especially those of us with asthma, allergy or other respiratory illnesses.

To combat indoor air pollution, air purifying technologies currently on the market such as HEPA make use of filters that capture and collect pollutants where they accumulate. By contrast, Molekule’s technology is able to eliminate pollutants 1000 times smaller than current filter such as this can catch.

Their technology works by using PECO (Photo Electrochemical Oxidation). This is a process that has resulted from 20 years of research and development by Dr. Yogi Goswami, a globally recognized expert in solar technology. The technology works when a nanoparticle-coated fibre is activated by light, generating a reaction on the surface of the filter, breaking down the pollutants including allergens, bacteria, viruses, mold and VOCs.

Molekule is carefully designed to integrate into today’s living environments. It’s technology allows Molekule to work extremely fast and quiety while it cleans and recirculates the air of a 60 square meter room every 60 minutes.

According to its creators, Molekule can be connected to Wi-Fi for the device to become smarter over time and respond to the individual needs of people’s household. The companion iOS app allows you to control the device remotely and seamlessly manage filter replacements.

Currently Molekule has four worldwide exclusive patents to this technology and one additional patent pending.